Application Nr Approved Date Route Status External Links
ANDA202871 2013-05-28 Oral RX Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

Indications & Usage Hypertension Metoprolol Tartrate Tablets Are Indicated For The Treatment Of Hypertension. They May Be Used Alone Or In Combination With Other Antihypertensive Agents. Angina Pectoris Metoprolol Tartrate Tablets Are Indicated In The Long-Term Treatment Of Angina Pectoris. Myocardial Infarction Metoprolol Tartrate Tablets Are Indicated In The Treatment Of Hemodynamically Stable Patients With Definite Or Suspected Acute Myocardial Infarction To Reduce Cardiovascular Mortality When Used Alone Or In Conjunction With Intravenous Metoprolol. Oral Metoprolol Therapy Can Be Initiated After Intravenous Metoprolol Therapy Or, Alternatively, Oral Treatment Can Begin Within 3 To 10 Days Of The Acute Event (see Dosage And Administration, Contraindications, And Warnings).

All Formulated Excipients (5 Total)

Name Structure Kind Function Status
1. Cellulose, Microcrystalline CELLULOSE, MICROCRYSTALLINE Unresolved
2. Lactose Monohydrate LACTOSE MONOHYDRATE Molecular
3. Povidones POVIDONES Unresolved
4. Croscarmellose Sodium CROSCARMELLOSE SODIUM Unresolved
5. Silicon Dioxide SILICON DIOXIDE Unresolved AC-Anticaking agent , MISC-Miscellaneous , STAB-Stabilizer GRAS-Generally recognized as safe.

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Metoprolol Tartrate METOPROLOL TARTRATE ZINC1530717